CVE-2026-70862Vulnerability in Oracle Application Testing Suite.
Updated under an hour ago ()
Does this affect you?
It affects Oracle Corporation Oracle Application Testing Suite. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
Vulnerability in Oracle Application Testing Suite. The supported version that is affected is 13.3.0.1. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Application Testing Suite. Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Oracle Application Testing Suite accessible data as well as unauthorized access to critical data or complete access to all Oracle Application Testing Suite accessible data. CVSS 3.1 Base Score 9.1 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N).
- CVSS
- 9.1 CRITICAL (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:N
- Weakness (CWE)
- CWE-284
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- oracle
- NVD analysis
- Analyzed
- Record last updated
- Aug 24, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
Oracle Corporation Oracle Application Testing Suite oracle:application_testing_suite (from the name) | 13.3.0.1 | CNA record |
oracle application_testing_suite oracle:application_testing_suite | 13.3.0.1 | NVD |
References
- https://www.oracle.com/security-alerts/cspuaug2026.htmlvendor-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.